Advaxis, Inc. Stock Nasdaq
Equities
US0076242082
Biotechnology & Medical Research
Financials (USD)
Sales * | - | Sales 1 * | - | Capitalization | 7.94M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - | Net cash position 1 * | - | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
1st Jan change | Capi. | |
---|---|---|
-0.75% | 41.36B | |
+44.25% | 41.3B | |
+2.38% | 39.61B | |
-15.14% | 25.62B | |
+5.00% | 24.09B | |
-24.11% | 18.38B | |
+25.60% | 11.85B | |
-1.97% | 11.82B | |
+8.52% | 11.07B |